279 abstracts found.



Segmentation of Head and Neck Cancer from MRI Data using Deep Neural network

Year:

Session type:

Theme:

Baixiang Zhao1,John Soraghan1,Gaetano Di-caterina1,Derek Grose2
1university of strathclyde,2Beatson West of Scotland Cancer Centre

Incidence and management of 3 years of immune mediated toxicities in metastatic non-small cell lung carcinoma (NSCLC) patients treated with anti PD-1/PD-L1 immunotherapy

Year:

Session type:

Theme:

Grace Tze-en Ding1,Colin Barrie1,Alan Simms2,Melanie Mackean3
1Edinburgh Cancer Centre,2Department of Radiology, NHS Lothian,3Edinburgh

Overcoming sorafenib resistance in hepatocellular carcinoma by fasting

Year:

Session type:

Theme:

Jelena Krstic1,Isabel Reinisch1,Maria Depaoli1,Natascha Berger2,Christoph Noessing3,Markus Galhuber1,Ines Anders4,Martina Auer1,Elisabeth Moyschewitz1,Beate Rinner5,Martin Pichler6,Roland Malli1,Andreas Prokesch1
1Medical University of Graz, Graz, Austria, Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Graz, Austria,2Department of Obstretics and Gynaecology, Medical University of Graz, Graz, Austria,3Cancer Research UK Beatson Institute, London, UK,4Medical University of Graz, Graz, Austria, Core Facility Alternative Biomodels and Preclinical Imaging, Graz, Austria,5Division of Biomedical Research, Medical University of Graz, Graz, Austria,6Division of Oncology, Medical University of Graz, Graz, Austria

Avoidable harm: making decisions about chemotherapy with advanced lung cancer patients

Year:

Session type:

Theme:

Annamarie Nelson1,Longo Mirella1,Stephanie Sivell1,Anthony Byrne1,Jason Lester2,Despina Anagnostou1,Catherine Sampson1
1Marie Curie Palliative Care Research Centre, Cardiff University, School of Medicine, Cardiff,2Velindre NHS Trust, Cardiff

Recurrence rates after low dose radioiodine ablation for differentiated thyroid cancer within the NCRI HiLo trial.

Year:

Session type:

Theme:

Jon Wadsley1,Hakim-Moulay Dehbi2,Ujjal Mallick3,Kate Newbold4,Clive Harmer5,Allan Hackshaw2

1Weston Park Hospital,2University College London, UK,3Freeman Hospital, Newcastle upon Tyne, UK,4Royal Marsden Hospital, Sutton, UK,5Formerly of the Royal Marsden Hospital, Sutton


Evaluating the trade-offs men with localised prostate cancer make between the risks and benefits of treatments: The COMPARE study

Year:

Session type:

Theme:

Hashim U. Ahmed1,Verity Watson2,Neil McCartan3,Nicolas Krucien2,Victor Abu4,Divine Ikenwilo2,Mark Emberton3

1Imperial College London,2Health Economics Research Unit, University of Aberdeen,3Research Department of Urology, Division of Surgery and Interventional Science, Faculty of Medicine, University College London,4Health and Social Care, Adult Nursing, London South Bank University


10 year cancer centre experience of treating metastatic kidney cancer

Year:

Session type:

Theme:

Rachel Jones1,Jones Rachel2
1Weston Park Hospital,2Sheffield University

The effects of thrombocytopenia during treatment with first-line cisplatin/gemcitabine on survival in patients with advanced biliary tract cancer.

Year:

Session type:

Theme:

Laura Johnston1,Noor Ul-Ain-Tariq2,Clare Hodgson2,Angela Lamarca2,Richard Hubner2,Juan Valle2,Mairead McNamara2
1University of Manchester,2The Christie NHS Trust

Overcoming chemoresistance in osteosarcoma: the role of autophagy in cell death or survival following chemotherapy

Year:

Session type:

Theme:

Gabriel Rosa1,Beata Burczynska1,Britta Stordal1,Helen Roberts1
1Middlesex University

Do brain metastases affect the efficacy of Nivolumab in patients with metastatic renal cell carcinoma?

Year:

Session type:

Theme:

Dan Muller1,Matthew Wheater1
1University Hospital Southampton

Therapeutic potential of novel thiosemicarbazones in pediatric oncology: combined treatment with vinca alkaloids.

Year:

Session type:

Theme:

Silvia Chovanova1,Maria Krchniakova2,Petr Chlapek2,Jaroslav Sterba3,Des Richardson4,Renata Veselska5
1,2Department of Experimental Biology, Faculty of Science, Masaryk University, Brno; International Clinical Research Center, St. Anne's University Hospital, Brno,3Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno,4Molecular Pharmacology and Pathology Program, Department of Pathology and Bosh Institute, University of Sydney, Sydney,5Department of Experimental Biology, Faculty of Science, Masaryk University, Brno; International Clinical Research Center, St. Anne's University Hospital, Brno; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno

Efficient elimination of B-lineage lymphomas using sortase A-generated site-specific anti-CD20-MMAE conjugates

Year:

Session type:

Theme:

Wen-bin Zhao1,Li-qiang Pan2,Wen-hui Liu1,Shu-qing Chen1
1Zhejiang university,2Harvard Medical School

Effectiveness and toxicity of EGFR-TKIs in elderly patients with EGFR-mutation positive NSCLC

Year:

Session type:

Theme:

Will Ince1,Saif Ahmad2,Stephanie Brown1,Matija Tausan1,Zacharias Tasigiannopoulos1,Konstantinos Geropantas1,Pinelopi Gkogkou1
1Norfolk and Norwich University Hospital,2Norfolk and Norwich

Real world experience of upfront docetaxel in metastatic hormone‑sensitive prostate cancer: a 4-year multi-centre review

Year:

Session type:

Theme:

James Bennett1,Claudia Ajayi1,Daniel Muller1,Jemma Longley1,Asfandyar Yousuf1,Ana Silva1,Chloe Holden2,Matthew Roberts3,Susannah Brock3,Simon Crabb1,Caroline Chau2
1University Hospital Southampton NHS Foundation Trust,2Portsmouth Hospitals NHS Trust,3Poole Hospital NHS Foundation Trust

Use of Theoretical Domains Framework to identify psychosocial determinants associated with adjuvant hormonal treatment adherence among breast cancer population: mixed method systematic review

Year:

Session type:

Theme:

Haley Ong1,Christine Campbell1,David Weller1
1University of Edinburgh

Patterns of post-mastectomy radiotherapy in patients with immediate breast reconstruction – Results from the iBRA-2 (immediate Breast Reconstruction and Adjuvant therapy) prospective cohort study

Year:

Session type:

Theme:

Tim Rattay1,Rachel O'Connell2,Rajiv Dave3,Matthew Gardiner4,Adam Trickey5,Chris Holcombe6,Shelley Potter5
1University of Leicester,2Royal Marsden Hospital,3University Hospitals of South Manchester,4University of Oxford,5University of Bristol,6Royal Liverpool and Broadgreen University Hospitals NHS Trust

PERSEPHONE: A randomised phase 3 non-inferiority trial of 6 versus 12 months (m) of adjuvant trastuzumab in patients with HER2 positive (+) early breast cancer (EBC)

Year:

Session type:

Theme:

Helena Earl1,Louise Hiller2,Anne-Laure Vallier1,Shrushma Loi3,Donna Howe2,Helen Higgins2,Karen McAdam1,Luke Hughes-Davies1,Adrian Harnett4,Mei-Lin Ah-See5,Richard Simcock6,Daniel Rea7,Janine Mansi8,Jean Abraham1,Carlos Caldas1,Claire Hulme9,David Miles5,Andrew Wardley10,David Cameron11,Janet Dunn2
1Cambridge University Hospitals,2University of Warwick,3University of Birmingham,4Norfolk and Norwich University Hospital,5Mount Vernon Cancer Centre,6Royal Sussex County Hospital,7Sandwell and West Birmingham Hospitals NHS Trust,8Guy's Hospital,9University of Leeds,10Christie Research Facility,11University of Edinburgh

PEARL: PET-based Adaptive Radiotherapy Clinical Trial

Year:

Session type:

Theme:

Martina Svobodova1,Sarah Hargreaves2,John Staffurth2,Max Robinson3,Rachel Butler4,Emiliano Spezi5,Rhydian Maggs2,Owain Woodley2,Vetri Jayaprakasam2,Chris Hurt1,Mererid Evans2,Thomas Rackley2
1Centre for Trials Research, Cardiff University,2Velindre Cancer Centre,3Royal Victoria Infirmary, Newcastle,4All Wales Genetics Laboratory, Cardiff and Vale Health Board,5School of Engineering, Cardiff University

No treatment field recurrence after Intra-Operative Electron Beam Radiotherapy (IOERT) for advanced and recurrent abdomino-pelvic cancers: Feasibility, safety, and medium term outcomes in a UK setting

Year:

Session type:

Theme:

Sheah Lin Lee1, Gui Han Lee2Rahul Bhome1,Kathryn Donovan2,Gillian Ansell2,Julian Smith2,Neil Pearce2,Adly Naga2,Claire Birch2,Andrew Bateman2, Alex Mirnezami2

1University of Southampton,2University Hospital Southampton


The LISTER feasibilty trial: A feasibility randomised controlled trial of Lugol’s iodine in the surgical treatment of oral and oropharyngeal Epithelial Dysplasia

Year:

Session type:

Theme:

Jim McCaul1,Stuart Hislop2,Abdul Ahmed3,Paul Norris4,Kishore Shekar5,Panos Kyzas6,David Sutton7,Rahul Jayaram3,Jacquline Quantrill8,Max Robinson9,Jeremy McMahon10
1Queen Elizabeth University Hospital,2Crosshouse Hospital, Kilmarnock,3Northwick Park Hospital,4Queen Victoria Hospital, East Grinstead,5Ninewells Hospital Dundee,6Pennine Acute NHS Trust,7Bradford Teaching Hospitals NHS Foundation Trust,8Bradford Institute for Health Research,9University of Newcastle,10Queen Elizabeth University Hospital, Glasgow

Automated brachytherapy seed counting with multimodal image registration on trained deep learning convolutional neural network

Year:

Session type:

Theme:

Rollo Moore1,Rollo Moore1,Ladislav Urban2,Yae-eun Suh3,Kate Roberts4,Derfel Ap Dafydd1,Vincent Khoo1
1The Royal Marsden NHS Foundation Trust,2Dynocortex,3The Royal Marsden Hospital NHS Trust,4The Royal Marsden NHS Trust

Arrayed CRISPR library screen to identify synthetic lethal partners of the histone methyltransferase KMT2D in diffuse large B cell lymphoma

Year:

Session type:

Theme:

Elizabeth Blaikley1,Mark Cockerill1,Cath Eberlein1,Ben Hodgson1,Graeme Walker1,Caroline Springer1
1CRUK Manchester Institute

Vismodegib for the treatment of locally advanced BCC – The East of England experience

Year:

Session type:

Theme:

David Maskell1,Dr Stephanie Browne2,Jenny Nobes2,Marc Moncrieff2,Amer Durrani3,Kate Fife3
1NHS,2Norfolk and Norwich University Hospital Foundation Trust,3Cambridge University Hospitals

Betulinic acid-doxorubicin drug combination synergistically supresses cell viability and enhances apoptotic death in acute myeloid leukaemia cell lines by increasing Bax/Bcl-2 ratio

Year:

Session type:

Theme:

Milan Vu1,Milan Vu2,Nick Kassouf2,Celia Bell2,Sandra Appiah2
1middlesex University,2Middlesex University

Melatonin regulates the tumor suppressor miR-148a-3p involved in angiogenesis and metastasis of breast cancer

Year:

Session type:

Theme:

Beatriz Camargo Lopes1,Jessica Zani Lacerda2,Livia Carvalho Ferriera2,Andres Felipe Aristizábal-Pachón3,Marcio Chaim Bajgelman4,Debora Aparecida Pires de Campos Zuccari5
1FAMERP,2Graduate Program in Biosciences/Universidade Estadual Paulista - UNESP/IBILCE, Sao Jose do Rio Preto (SP).,3Department of Genetics/Faculdade de Medicina - USP, Ribeirão Preto (SP).,4Laboratorio Nacional de Biociencias/Centro Nacional de Pesquisa em Energia e Materiais - CNPEM, Campinas (SP).,5Laboratorio de Investigação Molecular do Cancer/Faculdade de Medicina de São José do Rio Preto - FAMERP, Sao Jose do Rio Preto (SP).

Vertebral fractures in patients treated with FOLFIRI-Cetuximab at the Edinburgh Cancer Centre

Year:

Session type:

Theme:

Amanda Swan1,Sally Clive1,Lesley Dawson1,Donna McGowan1,Catriona McLean1,Hamish Phillips1,Maria Sakala1,Mark Zahra1,Ewan Brown1
1Edinburgh Cancer Centre

Improving patient experience of immunotherapy treatment for melanoma: the Leeds nurse-led immunotherapy telephone clinic

Year:

Session type:

Theme:

Maria Marples1,Helen Jackson1,Helen Nicholson1,Beverley Ryder1,Karen Ingham1,Jane Hook1
1Leeds Cancer Centre

Aspirin use after radical cancer therapy – feasibility and toxicity data from the Add-Aspirin trial

Year:

Session type:

Theme:

Nalinie Joharatnam1,Fay Cafferty1,Alistair Ring2,Howard Kynaston3,Richard Wilson4,Duncan Gilbert5,David Cameron6,Farhat Din6,Richard Hubner7,Anne Thomas8,Daniel Swinson9,Janusz Jankowski10,Sam Rowley11,Martin Scott-Brown12,Chris Price13,Alex Walther14,David Eaton15,Nicola Ainsworth16,Rachel Kerr17,Luke Hughes-Davies18,Max Parmar1,Conjeeveram Pramesh19,Sudeep Gupta19,Ruth Langley1
1MRC Clinical Trials Unit at UCL,2The Royal Marsden NHS Foundation Trust,3Cardiff and Vale University Health Board,4Queen's University Belfast,5Brighton and Sussex University Hospitals NHS Trust,6The University of Edinburgh,7The Christie NHS Foundation Trust,8University Hospitals of Leicester,9Leeds Teaching Hospitals NHS Trust,10University of Central Lancashire,11MRC CTU at UCL,12University Hospitals of Coventry and Warwickshire NHS Trust,13Worcestershire Acute Hospitals NHT Trust,14University Hospitals Bristol NHS Foundation Trust,15University Hospitals of Morecambe Bay NHS Foundation Trust,16The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust,17Oxford University Hospitals NHS Trust,18Cambridge University Hospitals NHS Foundation Trust,19Tata Memorial Centre

The use of selenium and vitamin E supplementation to prevent recurrence of non-muscle-invasive bladder cancer: results of the SELENIB trial

Year:

Session type:

Theme:

Richard Bryan1,Sarah Pirrie1,Ben Abbotts1,Vinnie During1,Carolyn Langford1,Margaret Grant1,Deborah Bird1,Adam Devall1,Gareth Bicknell1,D Michael A Wallace1,Nicholas James1,Lucinda Billingham1,Maurice Zeegers2,Kar Keung Cheng1
1University of Birmingham,2University of Birmingham & University of Maastricht

Structure-based virtual screening identifies natural compounds as VEGFR2 back-to-front inhibitors.

Year:

Session type:

Theme:

Shailima Rampogu1,Minky Son1,Ayoung Baek1,Chanin Park1,Keun Woo Lee1
1Gyeongsang National University

Management of rectal cancer after chemo-radiotherapy: A single centre review of patient outcomes after surgical management or ‘watch and wait’

Year:

Session type:

Theme:

Debbie Williamson1,Sophia Panayi2,Shabbir Susnerwala1,Nigel Scott1,Alan Beveridge1,Arnab Bhowmick1,Alka Jadav1,Peter Mitchell1,Ioannis Peristerakis1,Tarek Hany1,Paul Barrow1
1Lancashire Teaching Hospitals NHS Trust,2University of Manchester

Sensitivity and Specificity of Sonographic detection and its biopsy in diagnosing Axillary Lymph Node metastasis in Breast Cancer.

Year:

Session type:

Theme:

Prashanth Balaji1,Aman Gajree1
1The Hillingdon Hospital

Legumain (LGMN) Regulation of Advanced Prostate Cancer via HSD17B4

Year:

Session type:

Theme:

Alice Ormrod1,Sharon Eddie1,Richard Williams1,Paul Mullan1
1Queen's University Belfast

‘Real-world’ analysis of immune checkpoint inhibitor-mediated hepatitis in patients with metastatic cancer treated at Cambridge University Hospitals NHS Foundation Trust (CUHFT)

Year:

Session type:

Theme:

Dana Shor1,George Mells2,Brendan O’Sullivan3,Pippa Corrie4,Sarah Welsh4
1Addenbrookes Hospital,2Department of Hepatology, Cambridge University Hospital NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ,3Department of Pharmacy, Cambridge University Hospital NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ,4Department of Oncology, Cambridge University Hospital NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ

Metastatic Renal Cancer: How many patients are we treating?

Year:

Session type:

Theme:

Kate Fife1,Jessica Clifton2,Sarah Nolasco1,Athena Matakidou1,Sarah Welsh1,Tim Eisen1
1Cambridge University Hospitals NHS Foundation Trust,2Cambridge University Medical School

Ethnicity and the surgical management of early breast cancer in over 163 000 women in England

Year:

Session type:

Theme:

Toral Gathani1,Isobel Barnes1,John Broggio2,Gillian Reeves1
1University of Oxford,2Public Health England

Improving treatment and care for older people with cancer

Year:

Session type:

Theme:

Rose Gray1,Kerry Allen2
1Cancer Research UK,2University of Birmingham

Cost effectiveness analyses of 6 versus 12 months of adjuvant trastuzumab in patients  with HER2 positive early breast cancer: Results from the PERSEPHONE trial

Year:

Session type:

Theme:

Claire Hulme1,Peter Hall2,Beth Shinkins3,Fadi Chehadah3,Chris McCabe4,Janet Dunn5,Louise Hiller5,Helena Earl6
1university of leeds,2University of Edinburgh,3University of Leeds,4Institute of Health Economics, Alberta,5University of Warwick,6Addenbrooke's Hospital, Cambridge

Progression free survival as a surrogate endpoint for overall survival in first-line therapy of advanced ovarian cancer: A Gynecologic Cancer InterGroup (GCIG) individual patient-level meta-analysis

Year:

Session type:

Theme:

Rosalind Glasspool1,Liz-Anne Lewsley2,Gennaro Daniele3,Adrian David Cook4,Nozomu Yanaihara5,Anna Tinker6,Gunnar Kristensen7,Petronella Ottevanger8,Gerasimos Aravantinos9,Ingrid A. Boere10,Robert Fruscio11,Anna K.L. Reyners12,Eric Pujade-Lauraine13,Andrea Harkin2,Sandro Pignata14,Tatsuo Kagimura15,Stephen Welch16,Eleni, Karamouza17,Stan Kaye18,Timothy Perren19,Susana N Banerjee20,Xavier Paoletti21
1Beatson West of Scotland Cancer Centre,2Cancer Research UK Clinical Trials Unit, Institute of Cancer Research, University of Glasgow, Glasgow,,3Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione G. Pascale”- IRCCS, Naples,4MRC Clinical Trials Unit at UCL, London,,5The Jikei University School of Medicine, Tokyo,6British Columbia Cancer Agency, Vancouver, BC,,7Norwegian Radium Hospital, Oslo,8Department of Medical Oncology, Radboud University Medical Center, Nijmegen,9Hellenic Cooperative Oncology Group (HeCOG), Athens,10Daniel den Hoed Cancer Center, Erasmus University Medical Center, Rotterdam,11University of Milan & Bicocca San Gerardo Hospital, Monza,,12University Medical Center, University of Groningen, Groningen,,13Universite Paris-Descartes, AP-HP, Paris,,14National Cancer Institute of Naples, Naples,,15Foundation for Biomedical Research and Innovation, Translational Research Informatics Center, Kobe,,16London Regional Cancer Program, London, ON,,17Ligue Nationale Contre le Cancer Meta-Analysis Platform, Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, Villejuif,,18The Institute of Cancer Research and The Royal Marsden Hospital, Sutton,19Leeds Teaching Hospitals NHS Trust, Leeds,20The Royal Marsden NHS Foundation Trust, London,,21Gustave Roussy Institute, Villejuif

Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy (RT) for high and intermediate risk squamous cell cancer of the oropharynx: the MeRInO Study

Year:

Session type:

Theme:

Claire Paterson1,Ian McCrea1,Sarah Allwood-Spiers1,Devlin Lynsey1,Lisa Hay1,Marimuthu Sankaralingam1,Philip McLoone2,Derek Grose1,Allan James1,Carolynn Lamb1,Mohammed Rizwanullah3,Christina Wilson1,Stefano Schipani1,Ioanna Nixon1,Maureen Thomson1,Mark McJury1,John Foster1,Aileen Duffton1
1NHS,2University of Glasgow,3N/A

Goblet cell carcinoid tumour of the appendix: outcomes following cytoreductive surgery (CRS) and hyperthermic intra-peritoneal chemotherapy (HIPEC)

Year:

Session type:

Theme:

Ann Williams1,Angela Lamarca2,Bipasha Chakrabarty3,Jorge Barriuso4,Mairéad G McNamara4,Richard A Hubner2,Paul Fulford5,Juan W Valle4,Sarah O’Dwyer6,Annamaria Minicozzi5
1University of Manchester and The Christie NHS Foundation Trust,2Department of Medical Oncology, The Christie NHS Foundation Trust,3Department of Pathology, The Christie NHS Foundation Trust,4Department of Medical Oncology, The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester,5Department of Surgery, The Christie NHS Foundation Trust,6Department of Surgery, The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester

Does robotic TME offer better oncological outcome for rectal cancer?

Year:

Session type:

Theme:

Patricia Tejedor1,M Fong1,F Luvisetto1,S Stefan1,S Naqvi1,J Conti1,K Flashman1,F Sagias1,J Khan1
1Portsmouth

Anticancer activity of arabinoxylan on human gastric adenocarcinoma cells in vitro

Year:

Session type:

Theme:

Qiuyu Wang1,Weili Li2,John Peat1
1Manchester Metropolitan University,2University of Chester

A Real-World Data Analysis into the Relative Prescribing Levels of Palbociclib across the UK on the Ibrance Patient Programme

Year:

Session type:

Theme:

Chloe Ollis-Smith1,Maria Dilleen1,M H Ruhe Chowdhury1
1Pfizer

CHEMICAL DERIVATIVES OF 5-CARBOXYL 8- HYDROQUINILINE TARGET LYSINE SPECIFIC DEMETHYLASES IN ACUTE MYELOID LEUKAEMIA

Year:

Session type:

Theme:

Laura Monaghan1,Matthew E. Massett1,Roderick P. Bunschoten1,Alex Hoose1,Robert M.J. Liskamp1,Heather G. Jørgensen1,Xu Huang1
1University of Glasgow

The combination of curcumin and doxorubicin shows a selective cytotoxic effect on acute myeloid leukaemia cell line

Year:

Session type:

Theme:

Noor Hasan1,Noor Hasan1,Helen Roberts1,Lucy Ghali1,Sandra Appiah1
1Middlesex University

Optimising the use of platinum chemotherapies in combination with the ATR inhibitor, AZD6738, in breast cancer.

Year:

Session type:

Theme:

Charlie Huins1,Sally Hall2,Christopher Ottley3,Gareth Veal4,Yvette Drew5
1none,2Newcaslte university,3Durham University,4Newcaslte University,5Newcastle University

Novel graded prognostic assessment for colorectal cancer patients with brain metastases

Year:

Session type:

Theme:

Byoung Hyuck Kim1,Hae Jin Park2,Kyubo Kim3,Eui Kyu Chie4
1SMG-SNU Boramae medical center,2Hanyang University College of Medicine,3Ewha Womans University College of Medicine,4Seoul National University College of Medicine

Cancer Medicines Outcomes Programme (CMOP): Better use of existing data to understand outcomes in a local population

Year:

Session type:

Theme:

Jennifer Laskey1,Julie Clarke1,Kelly Baillie1,Yvonne Semple1,Olivia Wu2,Christine Crearie1,Rob Jones1,Ashita Waterston1,Tanja Mueller3,Jiafeng Pan3,Marion Bennie3
1NHS Greater Glasgow and Clyde,2University of Glasgow,3University of Strathclyde

FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 3-year normal tissue effects

Year:

Session type:

Theme:

A Murray Brunt1,Joanne Haviland2,Mark Sydenham2,Abdulla Alhasso3,David Bloomfield4,Charlie Chan5,Mark Churn6,Susan Cleator7,Charlotte Coles8,Marie Emson2,Andrew Goodman9,Clare Griffin2,Adrian Harnett10,Penny Hopwood2,Anna Kirby11,Cliona Kirwan12,Carolyn Morris13,Elinor Sawyer14,Navita Somaiah2,Isabel Syndikus15,Maggie Wilcox13,Zotova Rada16,Duncan Wheatley17,Judith Bliss2,John Yarnold2
1University Hospitals of North Midlands NHS Trust and Keele University,2The Institute of Cancer Research,3The Beatson West of Scotland Cancer Centre,4Brighton and Sussex University Hospitals NHS Trust,5Nuffield Health Cheltenham Hospital,6Worcestershire Acute Hospitals NHS Trust,7Imperial College Healthcare NHS Trust,8Cambridge University Hospitals NHS Foundation Trust,9Royal Devon and Exeter NHS Foundation Trust,10Norfolk and Norwich University Hospitals NHS Foundation Trust,11The Royal Marsden Hospital NHS Foundation Trust,12Manchester University NHS Foundation Trust,13Independent Cancer Patients' Voice,14Guy's and St Thomas' NHS Foundation Trust,15Wirral University Teaching Hospital NHS Foundation Trust,16RTTQA Mount Vernon Hospital,17Royal Cornwall Hospitals NHS Trust